Literature DB >> 31068256

Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations.

Andrea Párniczky1, Tamás Lantos2, Eszter Margit Tóth3, Zsolt Szakács4, Szilárd Gódi5, Roland Hágendorn6, Dóra Illés7, Balázs Koncz7, Katalin Márta4, Alexandra Mikó8, Dóra Mosztbacher9, Balázs Csaba Németh10, Dániel Pécsi4, Anikó Szabó4, Ákos Szücs11, Péter Varjú4, Andrea Szentesi12, Erika Darvasi7, Bálint Erőss4, Ferenc Izbéki13, László Gajdán13, Adrienn Halász13, Áron Vincze5, Imre Szabó5, Gabriella Pár5, Judit Bajor5, Patrícia Sarlós5, József Czimmer5, József Hamvas14, Tamás Takács7, Zoltán Szepes7, László Czakó7, Márta Varga15, János Novák16, Barnabás Bod17, Attila Szepes18, János Sümegi19, Mária Papp20, Csaba Góg21, Imola Török22, Wei Huang23, Qing Xia23, Ping Xue24, Weiqin Li25, Weiwei Chen26, Natalia V Shirinskaya27, Vladimir L Poluektov28, Anna V Shirinskaya28, Péter Jenő Hegyi29, Marian Bátovský30, Juan Armando Rodriguez-Oballe31, Isabel Miguel Salas31, Javier Lopez-Diaz32, J Enrique Dominguez-Munoz32, Xavier Molero33, Elizabeth Pando34, María Lourdes Ruiz-Rebollo35, Beatriz Burgueño-Gómez35, Yu-Ting Chang36, Ming-Chu Chang36, Ajay Sud37, Danielle Moore37, Robert Sutton37, Amir Gougol38, Georgios I Papachristou38, Yaroslav Mykhailovych Susak39, Illia Olehovych Tiuliukin39, António Pedro Gomes40, Maria Jesus Oliveira40, David João Aparício40, Marcel Tantau41, Floreta Kurti42, Mila Kovacheva-Slavova43, Stephanie-Susanne Stecher44, Julia Mayerle44, Goran Poropat45, Kshaunish Das46, Marco Vito Marino47, Gabriele Capurso48, Ewa Małecka-Panas49, Hubert Zatorski49, Anita Gasiorowska50, Natalia Fabisiak50, Piotr Ceranowicz51, Beata Kuśnierz-Cabala51, Joana Rita Carvalho52, Samuel Raimundo Fernandes52, Jae Hyuck Chang53, Eun Kwang Choi54, Jimin Han55, Sara Bertilsson56, Hanaz Jumaa57, Gabriel Sandblom58, Sabite Kacar59, Minas Baltatzis60, Aliaksandr Vladimir Varabei61, Vizhynis Yeshy62, Serge Chooklin63, Andriy Kozachenko64, Nikolay Veligotsky65, Péter Hegyi66.   

Abstract

BACKGROUND: Unwarranted administration of antibiotics in acute pancreatitis presents a global challenge. The clinical reasoning behind the misuse is poorly understood. Our aim was to investigate current clinical practices and develop recommendations that guide clinicians in prescribing antibiotic treatment in acute pancreatitis.
METHODS: Four methods were used. 1) Systematic data collection was performed to summarize current evidence; 2) a retrospective questionnaire was developed to understand the current global clinical practice; 3) five years of prospectively collected data were analysed to identify the clinical parameters used by medical teams in the decision making process, and finally; 4) the UpToDate Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system was applied to provide evidence based recommendations for healthcare professionals.
RESULTS: The systematic literature search revealed no consensus on the start of AB therapy in patients with no bacterial culture test. Retrospective data collection on 9728 patients from 22 countries indicated a wide range (31-82%) of antibiotic use frequency in AP. Analysis of 56 variables from 962 patients showed that clinicians initiate antibiotic therapy based on increased WBC and/or elevated CRP, lipase and amylase levels. The above mentioned four laboratory parameters showed no association with infection in the early phase of acute pancreatitis. Instead, procalcitonin levels proved to be a better biomarker of early infection. Patients with suspected infection because of fever had no benefit from antibiotic therapy.
CONCLUSIONS: The authors formulated four consensus statements to urge reduction of unjustified antibiotic treatment in acute pancreatitis and to use procalcitonin rather than WBC or CRP as biomarkers to guide decision-making.
Copyright © 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Antibiotic; Guideline; Infection; Recommendation

Mesh:

Substances:

Year:  2019        PMID: 31068256     DOI: 10.1016/j.pan.2019.04.003

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  13 in total

1.  Insufficient implementation of the IAP/APA guidelines on aetiology in acute pancreatitis: Is there a need for implementation managers in pancreatology?

Authors:  Noémi Zádori; Andrea Párniczky; Andrea Szentesi; Péter Hegyi
Journal:  United European Gastroenterol J       Date:  2020-04       Impact factor: 4.623

2.  Tricetin Reduces Inflammation and Acinar Cell Injury in Cerulein-Induced Acute Pancreatitis: The Role of Oxidative Stress-Induced DNA Damage Signaling.

Authors:  Máté Nagy-Pénzes; Zoltán Hajnády; Zsolt Regdon; Máté Á Demény; Katalin Kovács; Tarek El-Hamoly; József Maléth; Péter Hegyi; Csaba Hegedűs; László Virág
Journal:  Biomedicines       Date:  2022-06-10

3.  EASY-APP: An artificial intelligence model and application for early and easy prediction of severity in acute pancreatitis.

Authors:  Balázs Kui; József Pintér; Roland Molontay; Marcell Nagy; Nelli Farkas; Noémi Gede; Áron Vincze; Judit Bajor; Szilárd Gódi; József Czimmer; Imre Szabó; Anita Illés; Patrícia Sarlós; Roland Hágendorn; Gabriella Pár; Mária Papp; Zsuzsanna Vitális; György Kovács; Eszter Fehér; Ildikó Földi; Ferenc Izbéki; László Gajdán; Roland Fejes; Balázs Csaba Németh; Imola Török; Hunor Farkas; Artautas Mickevicius; Ville Sallinen; Shamil Galeev; Elena Ramírez-Maldonado; Andrea Párniczky; Bálint Erőss; Péter Jenő Hegyi; Katalin Márta; Szilárd Váncsa; Robert Sutton; Peter Szatmary; Diane Latawiec; Chris Halloran; Enrique de-Madaria; Elizabeth Pando; Piero Alberti; Maria José Gómez-Jurado; Alina Tantau; Andrea Szentesi; Péter Hegyi
Journal:  Clin Transl Med       Date:  2022-06

Review 4.  Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2020-01-04       Impact factor: 5.923

5.  Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19.

Authors:  Péter Hegyi; Zsolt Szakács; Miklós Sahin-Tóth
Journal:  Gastroenterology       Date:  2020-07-17       Impact factor: 22.682

6.  Investigation of antibiotic use in patients with acute pancreatitis in a Vietnamese hospital.

Authors:  Vo Duy Thong; Trinh Thi Hong Anh; Bui Thi Huong Quynh; Ngo Thi Thanh Quyt
Journal:  JGH Open       Date:  2020-12-02

7.  Proton Pump Inhibitors Were Associated With Reduced Pseudocysts in Acute Pancreatitis: A Multicenter Cohort Study.

Authors:  Shengyu Zhang; Ziying Han; Yuelun Zhang; Xiaomao Gao; Shicheng Zheng; Ruifeng Wang; Dong Wu
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

8.  Clostridioides difficile Infection Is Associated with Adverse Outcomes among Hospitalized Pediatric Patients with Acute Pancreatitis.

Authors:  Aravind Thavamani; Krishna Kishore Umapathi; Jasmine Khatana; Senthilkumar Sankararaman
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-01-07

9.  Hypoalbuminemia affects one third of acute pancreatitis patients and is independently associated with severity and mortality.

Authors:  Klementina Ocskay; Zsófia Vinkó; Dávid Németh; László Szabó; Judit Bajor; Szilárd Gódi; Patrícia Sarlós; László Czakó; Ferenc Izbéki; József Hamvas; Mária Papp; Márta Varga; Imola Török; Artautas Mickevicius; Ville Sallinen; Elena Ramirez Maldonado; Shamil Galeev; Alexandra Mikó; Bálint Erőss; Marcell Imrei; Péter Jenő Hegyi; Nándor Faluhelyi; Orsolya Farkas; Péter Kanizsai; Attila Miseta; Tamás Nagy; Roland Hágendorn; Zsolt Márton; Zsolt Szakács; Andrea Szentesi; Péter Hegyi; Andrea Párniczky
Journal:  Sci Rep       Date:  2021-12-17       Impact factor: 4.379

10.  Evaluation of four scoring systems in prognostication of acute pancreatitis for elderly patients.

Authors:  Yajie Li; Jun Zhang; Jihong Zou
Journal:  BMC Gastroenterol       Date:  2020-06-01       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.